Journal article

Dual HER2 Blockade

Christoph Thomssen, Nagi S El Saghir, Prudence A Francis, Jacek Jassem, Hope S Rugo, Michael Untch

Breast Care | KARGER | Published : 2017

DOI: 10.1159/000484226

Keywords

Trastuzumab
Lapatinib
Oncology
Life Sciences & Biomedicine
Her2-Positive Breast-Cancer
Obstetrics & Gynecology
Open-Label
Therapy
Multicenter
Science & Technology
Phase-3 Trial